Your browser doesn't support javascript.
loading
AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis.
Kim, Dae Gyu; Choi, Yongseok; Lee, Yuno; Lim, Semi; Kong, Jiwon; Song, JaeHa; Roh, Younah; Harmalkar, Dipesh S; Lee, Kwanshik; Goo, Ja-Il; Cho, Hye Young; Mushtaq, Ameeq Ul; Lee, Jihye; Park, Song Hwa; Kim, Doyeun; Min, Byung Soh; Lee, Kang Young; Jeon, Young Ho; Lee, Sunkyung; Lee, Kyeong; Kim, Sunghoon.
Afiliação
  • Kim DG; Medicinal Bioconvergence Research Center, Institute for Artificial Intelligence and Biomedical Research, College of Pharmacy & College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon, Korea.
  • Choi Y; Department of Biotechnology, Korea University, Seoul, Korea.
  • Lee Y; Drug Information Research Center, Korea Research Institute of Chemical Technology, Daejeon, Korea.
  • Lim S; Medicinal Bioconvergence Research Center, Institute for Artificial Intelligence and Biomedical Research, College of Pharmacy & College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon, Korea.
  • Kong J; Medicinal Bioconvergence Research Center, Institute for Artificial Intelligence and Biomedical Research, College of Pharmacy & College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon, Korea.
  • Song J; Medicinal Bioconvergence Research Center, Institute for Artificial Intelligence and Biomedical Research, College of Pharmacy & College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon, Korea.
  • Roh Y; Medicinal Bioconvergence Research Center, Institute for Artificial Intelligence and Biomedical Research, College of Pharmacy & College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon, Korea.
  • Harmalkar DS; Department of Biotechnology, Korea University, Seoul, Korea.
  • Lee K; College of Pharmacy, Dongguk University, Goyang, Korea.
  • Goo JI; Department of Biotechnology, Korea University, Seoul, Korea.
  • Cho HY; Department of Biotechnology, Korea University, Seoul, Korea.
  • Mushtaq AU; College of Pharmacy, Korea University, Sejong, Korea.
  • Lee J; College of Pharmacy, Korea University, Sejong, Korea.
  • Park SH; Medicinal Bioconvergence Research Center, Institute for Artificial Intelligence and Biomedical Research, College of Pharmacy & College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon, Korea.
  • Kim D; Medicinal Bioconvergence Research Center, Institute for Artificial Intelligence and Biomedical Research, College of Pharmacy & College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon, Korea.
  • Min BS; Medicinal Bioconvergence Research Center, Institute for Artificial Intelligence and Biomedical Research, College of Pharmacy & College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon, Korea.
  • Lee KY; Department of Surgery, College of Medicine, Yonsei University, Seoul, Korea.
  • Jeon YH; Department of Surgery, College of Medicine, Yonsei University, Seoul, Korea.
  • Lee S; College of Pharmacy, Korea University, Sejong, Korea.
  • Lee K; Drug Information Research Center, Korea Research Institute of Chemical Technology, Daejeon, Korea.
  • Kim S; College of Pharmacy, Dongguk University, Goyang, Korea. kaylee@dongguk.edu.
Nat Commun ; 13(1): 2572, 2022 05 11.
Article em En | MEDLINE | ID: mdl-35546148
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas p21(ras) / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas p21(ras) / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article